0

Aramchol

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP246529226
CAS246529-22-6
Molecular Weight702.10
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Current and Emerging Pharmacological Therapy for Non-Alcoholic Fatty Liver Disease

Ahad Eshraghian

World J Gastroenterol. 2017 Nov 14;23(42):7495-7504.

PMID: 29204050

1

Current and Future Pharmacological Therapies for NAFLD/NASH

Yoshio Sumida, Masashi Yoneda

J Gastroenterol. 2018 Mar;53(3):362-376.

PMID: 29247356

1

Current and Upcoming Pharmacotherapy for Non-Alcoholic Fatty Liver Disease

Yaron Rotman, Arun J Sanyal

Gut. 2017 Jan;66(1):180-190.

PMID: 27646933

1

MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial)

Veeral H Ajmera, Edward Cachay, Christian Ramers, Irine Vodkin, Shirin Bassirian, Seema Singh, Neeraj Mangla, Richele Bettencourt, Jeannette L Aldous, Daniel Park, Daniel Lee, Jennifer Blanchard, Adrija Mamidipalli, etc.

Hepatology. 2019 Nov;70(5):1531-1545.

PMID: 31013363

1

Novel Pharmacotherapy Options for NASH

Vlad Ratziu

Dig Dis Sci. 2016 May;61(5):1398-405.

PMID: 27003143

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode